I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Confirmed 6-Month Disability Improvement and Worsening Corr..:
Hunter, Samuel F
;
Aburashed, Rany A
;
Alroughani, Raed
...
2193-8253. , 2021
Link:
http://hdl.handle.net/10668/18038
RT Journal T1
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_18038&Exemplar=1&LAN=DE A1 Hunter, Samuel F A1 Aburashed, Rany A A1 Alroughani, Raed A1 Chan, Andrew A1 Dive, Dominique A1 Eichau, Sara A1 Kantor, Daniel A1 Kim, Ho Jin A1 Lycke, Jan A1 Macdonell, Richard A L A1 Pozzilli, Carlo A1 Scott, Thomas A1 Sharrack, Basil A1 Wiendl, Heinz A1 Chung, Luke A1 Daizadeh, Nadia A1 Baker, Darren P A1 Vermersch, Patrick A1 CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators YR 2021 K1 Alemtuzumab K1 Confirmed disability improvement K1 Confirmed disability worsening K1 Disease-modifying therapy K1 Expanded Disability Status Scale K1 Functional systems K1 Multiple sclerosis JF 2193-8253 LK http://hdl.handle.net/10668/18038 DO http://hdl.handle.net/10668/18038 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)